Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter
Keywords: مالیات بر ارزش افزوده; MVA; Viral vector; Promoter; Transgene expression; Immunogenicity; Vaccine development;